U.S. Healthtech Stock News

With the Federal Reserve holding rates steady at 3.5% to 3.75% and signaling a steady, data focused approach under Chair Kevin Warsh, many investors are looking again at stable dividend paying blue chip stocks as potential anchors for their portfolios. Policy stability, ongoing geopolitical tension, and volatile oil prices are creating a mixed backdrop, but consistent dividends and stronger balance sheets can help smooth some of that noise. This article walks through three stocks from our...

In recent months, TFS Financial Corp has reported modest year-over-year improvements in quarterly revenue and net profit, even as some financial datapoints remain undisclosed and its operating efficiency score lags most peers in the Banking Services industry. At the same time, institutional ownership has climbed to the highest rank in its sector, with firms such as Dimensional Fund Advisors, BlackRock, State Street, and investor James Simons all increasing their stakes, signaling strong...

Why Zymeworks’ Cryo‑EM Breakthrough Matters for the Stock Zymeworks (ZYME) just reported a collaboration with Gandeeva Therapeutics that used high resolution cryo electron microscopy to map a small antigen bound to a Zymeworks antibody, sharpening insight into antibody epitope binding. For you as a shareholder or potential investor, the key point is that this work goes beyond a headline partnership announcement and delivers specific structural data, including a 2.6 Å view of nine amino acids...

Worthington Steel (WS) is back in focus after reporting quarterly revenue of US$769.80 million and net profit growth of 24.64% year over year, figures that sharply contrast with mixed technical signals. See our latest analysis for Worthington Steel. At a latest share price of US$40.73, Worthington Steel’s 1-day share price return of 3.90% contrasts with a 7-day decline of 6.26%. Its 1-year total shareholder return of 69.30% and 90-day share price return of 24.82% point to momentum that has...

Talks between Russia and China over the Power of Siberia 2 gas pipeline, combined with disruption risks around the Strait of Hormuz, are reshaping how investors think about global energy infrastructure. Changing trade routes, unresolved pricing and financing questions, and shifting export priorities can affect everything from earnings stability to access to capital for pipeline and midstream companies. This article walks through 3 stocks from our Global Energy Infrastructure and Natural Gas...

Conexeu Sciences (CNXU) has drawn fresh attention after expanding its board and executive team, including naming co founder David Bogart as Chief Commercial Officer, as it moves its CXU wound care platform toward FDA 510(k) preparation. See our latest analysis for Conexeu Sciences. Recent appointments around the CXU platform come after a period of mixed trading, with a 7 day share price return of 17.63% and a 30 day share price return that declined 7.78% from a latest close of $13.28. This...

The Federal Reserve’s signal that it may slow interest rate hikes, along with moderating inflation and softer Treasury yields, is reshaping how investors think about growth stocks. When borrowing costs and inflation pressures shift, expectations for future earnings and valuations can also change. Some companies with solid market value and healthier balance sheets may look better placed than others if financing conditions become less restrictive. This article walks through three growth focused...

Cooling core inflation at 3.3% and a softer 1.6% GDP print are giving investors a mixed signal, while headline inflation at 3.8% and higher gasoline prices keep pressure on the energy sector. With some traders now expecting the Fed to hold rates longer and even consider a hike in early 2025, pricing power, balance sheet strength, and exposure to consumer spending all matter more. This article discusses three U.S. energy sector stocks from our screener that appear particularly exposed to these...

Smith & Wesson Brands, Inc. has reported past fourth-quarter 2026 sales of US$178.39 million and net income of US$16.22 million, alongside full-year sales of US$523.85 million and net income of US$18.48 million, and announced a quarterly dividend of US$0.13 per share payable on July 15, 2026. The combination of higher year-over-year quarterly and annual earnings per share from continuing operations and the continued cash return via dividends highlights management’s focus on both...

In the past few days, Acushnet Holdings reported quarterly results showing revenue growth and a larger increase in net profit, alongside strong price momentum and supportive technical indicators. Despite slightly weaker institutional ownership and a relatively high earnings multiple, the company’s combination of improving earnings and top-ranked momentum appears to be reinforcing investor confidence in its underlying golf-focused business. Now we’ll explore how this combination of stronger...

Global trade is becoming more fragmented, with higher tariffs, protectionist policies and fresh risks to cross border digital commerce. That mix can create headwinds for companies built on long supply chains, while potentially giving an edge to businesses that earn most of their revenue closer to home. This article looks at how the latest World Trade Organization developments and geopolitical tensions might affect a group of stocks exposed to these shifts in trade, and highlights 3...

Global markets are being pulled in different directions by inflation headlines, shifting central bank signals, and energy and trade data, so it is no surprise that many investors are focusing on companies where analysts still see solid earnings growth potential and reasonably sound balance sheets. The Healthy high growth potential screener filters for exactly that, highlighting stocks that analysts expect to grow earnings over the next 3 years while meeting basic financial strength checks. In...

Franklin Electric recently reported past quarterly results showing revenue up 9.93% year-over-year and net profit up 10.91%, with a financial health score of 7.04 and average operating efficiency versus peers. At the same time, bullish technical indicators pointing to a buy signal and strong price momentum highlight how current trading trends are aligning with the company’s healthier fundamentals. Now we’ll examine how this combination of solid quarterly revenue and profit growth may...

Black Hills Corp. recently reported continued progress on its proposed 1.8‑gigawatt data center project in Cheyenne, Wyoming, including equipment procurement, over US$200,000,000 in refundable customer construction contributions, and regulatory filings to support new substation infrastructure. An interesting aspect is that the prospective large-load customer is directly funding long lead-time generation milestones and substation development, signaling strong commitment to this long-horizon...

Cellebrite DI (NasdaqGS:CLBT) is drawing fresh attention after announcing general availability of Cellebrite Genesis, an AI-driven digital evidence tool that early law enforcement users report is reshaping how complex investigations are handled. See our latest analysis for Cellebrite DI. The Cellebrite DI share price has pulled back in recent months, with a 90 day share price return of 10.09% and a year to date share price return of 28.08% in the red. However, the 3 year total shareholder...

If you are wondering whether Royal Gold at around US$214.82 really offers value today, the first step is understanding what the current share price is and is not telling you. The stock is up 3.5% over the last week, even though it is down 3.4% over the last 30 days and down 2.8% year to date, while the 1 year and 3 year returns of 20.8% and 95.0% put its recent performance in a very different light. Recent coverage has focused on how Royal Gold fits into the broader materials and mining...

CME Group (NasdaqGS:CME) has filed a lawsuit against the Commodity Futures Trading Commission over the regulator's approval of crypto perpetual futures. The case centers on how these perpetual futures are classified under Dodd-Frank and raises concerns about regulatory arbitrage and benchmark licensing. This dispute marks a rare public clash between CME Group and its primary U.S. derivatives regulator. CME Group, the operator of major futures and options exchanges, sits at the center of...

Fabrinet (NYSE:FN) is being included in a new lineup of leveraged single stock ETFs. The ETF provider has announced the addition as part of an expanding leveraged product range. This move is expected to affect trading patterns by increasing short term activity and speculation in Fabrinet shares. Fabrinet enters this ETF-related spotlight with a current share price of $573.76 and a value score of 3. The stock is up 19.7% year to date and has gained 115.5% over the past year. Returns over the...

With the S&P 500 trading on a forward P/E of 21.1 versus a 10 year average of 18.9, rich valuations, heavy AI expectations and a concentrated technology sector are leaving many investors wondering where to find steadier ground. This is where low volatility stocks can become interesting, especially when inflation is still above the Fed’s 2% target and further rate moves are on the table. Below, three stocks from a low volatility screener, all exposed to these market drivers in different ways,...

In late May 2026, RBC Capital began covering Black Stone Minerals, L.P. with a Sector Perform rating, citing its 76% gas-weighted asset base and expectations for production growth into 2026, supported by active development across core regions. The firm also highlighted increased natural gas activity in Louisiana and strong oil volumes from the Permian Basin, underscoring how Black Stone’s diversified mineral and royalty interests are being worked by multiple operators to support its current...

Immunovant (IMVT) is back in focus after reporting a wider than expected quarterly loss tied to IMVT-1402 development and batoclimab discontinuation costs, along with updates on its Graves' Disease and CIDP programs. See our latest analysis for Immunovant. Against that backdrop, Immunovant’s share price has risen strongly, with a 90 day share price return of 53.79% and a 1 year total shareholder return of 123.67%, signaling firm momentum as investors weigh its IMVT-1402 and CIDP updates. If...

Global markets are absorbing fresh economic data and new regulatory rules, and that mix is quietly reshaping where risk and resilience sit in many portfolios. Large, well capitalised companies that already operate under tight rules can sometimes turn regulatory complexity into a competitive advantage, while others face tougher headwinds. This article looks at three regulation resilient blue chip stocks that are closely exposed to the latest macro and policy shifts, and explains why some...

Academy Sports and Outdoors, Inc. recently reported first-quarter 2026 results, with sales rising to US$1,442 million and net income increasing to US$52.7 million, lifting both basic and diluted earnings per share from continuing operations compared with a year earlier. This earnings improvement, built on higher revenue and profitability, offers fresh evidence of operational progress that could influence how investors view the company’s longer-term earnings profile. With first-quarter sales...

Dividend affirmation and upcoming earnings put Methode Electronics in focus Methode Electronics (MEI) has affirmed a quarterly dividend of US$0.0500 per share while preparing to release fourth quarter and full year fiscal 2026 results on June 24, keeping both income and earnings firmly in view. See our latest analysis for Methode Electronics. Methode Electronics’ share price has moved sharply ahead of the upcoming earnings release, with a 1-day share price return of 21.18% and a 90-day share...